Kui Luo

15.3k total citations · 14 hit papers
287 papers, 12.4k citations indexed

About

Kui Luo is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Kui Luo has authored 287 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Biomedical Engineering, 96 papers in Biomaterials and 90 papers in Molecular Biology. Recurrent topics in Kui Luo's work include Nanoplatforms for cancer theranostics (119 papers), Nanoparticle-Based Drug Delivery (89 papers) and RNA Interference and Gene Delivery (53 papers). Kui Luo is often cited by papers focused on Nanoplatforms for cancer theranostics (119 papers), Nanoparticle-Based Drug Delivery (89 papers) and RNA Interference and Gene Delivery (53 papers). Kui Luo collaborates with scholars based in China, United States and United Kingdom. Kui Luo's co-authors include Zhongwei Gu, Qiyong Gong, Hu Zhang, Bin He, Dayi Pan, Yuji Pu, Hao Cai, Hongyan Zhu, Qingqing Pan and Xuelei Ma and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Kui Luo

277 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

2022 487 citations Hu Zhang, Zhongwei Gu et al. Advanced Science profile →
Preparation and application of pH-responsive drug delivery systems

2022 364 citations Haitao Ding, Xiaohe Tian et al. Journal of Controlled Release profile →
Artificial intelligence aids in development of nanomedicines for cancer management

2023 175 citations Hu Zhang, Kui Luo et al. profile →
Copper-based metal–organic frameworks for biomedical applications

2022 170 citations Ju‐E Cun, Fan Xi et al. profile →
Stimuli-activatable nanomedicine meets cancer theranostics

2023 154 citations Haonan Li, Qiang Luo et al. Theranostics profile →
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective

2024 107 citations Kui Luo et al. profile →
A Double Network Composite Hydrogel with Self-Regulating Cu²⁺/Luteolin Release and Mechanical Modulation for Enhanced Wound Healing

2024 92 citations Qingqing Pan, Kui Luo et al. profile →
Biomarker-driven molecular imaging probes in radiotherapy

2024 86 citations Haonan Li, Qiyong Gong et al. Theranostics profile →
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response

2024 75 citations Dayi Pan, Yunkun Li et al. profile →
Chitosan-based hydrogel dressings for diabetic wound healing via promoting M2 macrophage-polarization

2024 73 citations Xuelian Wei, Zhiqian Li et al. profile →
Metformin-based nanomedicines for reprogramming tumor immune microenvironment

2024 71 citations Qiyong Gong, Kui Luo et al. Theranostics profile →
Nano drug delivery systems for advanced immune checkpoint blockade therapy

2025 52 citations Chenqi Guo, Ling Lin et al. Theranostics profile →
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy

2024 47 citations Zhiqian Li, Dayi Pan et al. profile →
Copper‐Based Bio‐Coordination Nanoparticle for Enhanced Pyroptosis‐Cuproptosis Cancer Immunotherapy through Redox Modulation and Glycolysis Inhibition

2025 19 citations Ju‐E Cun, Fan Xi et al. profile →

Peers

Countries citing papers authored by Kui Luo

Since Specialization

Citations

This map shows the geographic impact of Kui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Luo more than expected).

Fields of papers citing papers by Kui Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Luo. The network helps show where Kui Luo may publish in the future.

Co-authorship network of co-authors of Kui Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Kui Luo. A scholar is included among the top collaborators of Kui Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kui Luo. Kui Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics 2025 ·Theranostics ·Yinggang Li, Xue Zhang, Yunkun Li, Ling Sun, Na Hu, Yi Lü, Zhenyu Duan, Qiyong Gong, Kui Luo	4
2	Nano drug delivery systems for advanced immune checkpoint blockade therapy breakdown → 2025 ·Theranostics ·Chenqi Guo, Ling Lin, Yihan Wang, Jing Jing, Qiyong Gong, Kui Luo	52
3	Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy 2025 ·Journal of Controlled Release ·Yuxin Zhang, (unknown), (unknown), (unknown), Yunkun Li, (unknown), Guohao Liu, Qiyong Gong, Kui Luo, Jing Jing	7
4	Chrono-controlled hydrogel platform orchestrates metabolic reprogramming and cuproptosis-driven immune activation against triple-negative breast cancer 2025 ·Biomaterials ·Yao Lu, Qingqing Pan, Kui Luo, Bin He, Yuji Pu	3
5	Targeting zincosomes to unveil lysosomal zinc ion dynamics and their role in exacerbating Alzheimer's pathology 2024 ·Sensors and Actuators B Chemical ·(unknown), Haitao Ding, Fengfeng Chen, Lei Hu, (unknown), Kui Luo, Liu‐Lin Xiong, Shiqian Qi, Xiaohe Tian	2
6	An umbrella review of socioeconomic status and cancer 2024 ·Nature Communications ·Li Shen, Yuxin He, Jifeng Liu, (unknown), (unknown), Kai Tao, Jiaqing Yang, Kui Luo, Xuelei Ma	26
7	Biomarker-driven molecular imaging probes in radiotherapy breakdown → 2024 ·Theranostics ·Haonan Li, Qiyong Gong, Kui Luo	86
8	Nano-enabled colorectal cancer therapy 2023 ·Journal of Controlled Release ·Qingqing Pan, Fan Xi, Li Xie, Di Wu, Rong Liu, Wenxia Gao, Kui Luo, Bin He, Yuji Pu	50
9	Unraveling Ros Conversion Through Enhanced Enzyme‐Like Activity with Copper‐Doped Cerium Oxide for Tumor Nanocatalytic Therapy 2023 ·Advanced Science ·Zhengxiang Gu, Dan Zhong, (unknown), Xuelian Wei, (unknown), (unknown), Zhenyu Duan, Zhongwei Gu, Qiyong Gong, Kui Luo	33
10	Low-irradiance PDT enhances tumor accumulation of 2ME-based nano-prodrug to achieve metastasis inhibition via HIF-1α suppression 2023 ·European Polymer Journal ·Peng Gao, (unknown), Zhiqian Li, Zhenyu Duan, Bing Wang, Jie Chen, Qiyong Gong, Kui Luo	1
11	Patterns of brain dynamic functional connectivity are linked with attention-deficit/hyperactivity disorder-related behavioral and cognitive dimensions 2023 ·Psychological Medicine ·Lekai Luo, Lizhou Chen, (unknown), (unknown), Ning He, Yuanyuan Li, Wanfang You, (unknown), Fenghua Long, Lanting Guo, Kui Luo, John A. Sweeney, Qiyong Gong, Fei Li	28
12	Revealing the amyloid β-protein with zinc finger protein of micronucleus during Alzheimer's disease progress by a quaternary ammonium terpyridine probe 2023 ·Biosensors and Bioelectronics ·Haitao Ding, (unknown), Wei Du, Liping Su, (unknown), Yupeng Tian, Dayi Pan, Lei Chen, Loris Rizzello, Xiaowei Zheng, Giuseppe Battaglia, Kui Luo, Qiyong Gong, Xiaohe Tian	2
13	An Iridium (III) complex revealing cytoskeleton nanostructures under super-resolution nanoscopy and liquid-phase electron microscopy 2023 ·Sensors and Actuators B Chemical ·Tianyan Liu, (unknown), (unknown), Giovanni Bruno, Tao Shao, Yupeng Tian, Bo Chen, Lei Chen, Kui Luo, Qiyong Gong, Lorena Ruiz‐Pérez, Giuseppe Battaglia, Xiaohe Tian	3
14	The More the Slower: Self-Inhibition in Supramolecular Chirality Induction, Memory, Erasure, and Reversion 2022 ·Journal of the American Chemical Society ·Jiecheng Ji, Xueqin Wei, Wanhua Wu, Chunying Fan, Da‐Yang Zhou, Kuppusamy Kanagaraj, Cheng Guo, Kui Luo, Xiang‐Gao Meng, Cheng Yang	64
15	Photo-enhanced upcycling H2O2 into hydroxyl radicals by IR780-embedded Fe3O4@MIL-100 for intense nanocatalytic tumor therapy 2022 ·Biomaterials ·Ju‐E Cun, Yang Pan, (unknown), Yao Lu, Junhua Li, Qingqing Pan, Wenxia Gao, Kui Luo, Bin He, Yuji Pu	88
16	Smart Multistage “Trojan Horse”-Inspired Bovine Serum Albumin-Coated Liposomes for Enhancing Tumor Penetration and Antitumor Efficacy 2022 ·Biomacromolecules ·Jianqin Yan, Chan Shan, (unknown), (unknown), Bin He, Yong Sun, Kui Luo, (unknown), Xianwen Wang, Yan Liang	13
17	Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation 2022 ·Chemical Society Reviews ·Haonan Li, Qiang Luo, Hu Zhang, Xuelei Ma, Zhongwei Gu, Qiyong Gong, Kui Luo	63
18	A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting 2021 ·Science Advances ·Yanmei He, (unknown), Jun Cao, Xiaotong Yang, Shengsheng Cai, Fan Tong, Dennis Huang, Heng Mei, Kui Luo, Huile Gao, Bin He, Nicholas A. Peppas	123
19	Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens 2021 ·Biomaterials ·Yao Lu, Qingqing Pan, Wenxia Gao, Yuji Pu, Kui Luo, Bin He, Zhongwei Gu	107
20	Confined Pool-Buried Water-Soluble Nanoparticles from Reverse Micelles 2017 ·Langmuir ·Yong Liu, Ying Chen, Yongchao Yao, Kui Luo, Shiyong Zhang, Zhongwei Gu	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact